StockData
AVXLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends September 30

ANAVEX LIFE SCIENCES CORP.

Financials through Q3 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 28, 2026
$1.25−0.06 (-4.58%)

Close on Oct 19, 2026

Market cap
$116.12B
P/E (TTM)
–
Dividend yield
–

ANAVEX LIFE SCIENCES CORP. revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

Anavex Life Sciences does not break out revenue by segment, region or product in the tagged data of its filings for this period type.